Frieri G - Search Results

1

Management of colonic diverticular disease.

Frieri G, Pimpo MT, Scarpignato C. Frieri G, et al. Digestion. 2006;73 Suppl 1:58-66. doi: 10.1159/000089780. Epub 2006 Feb 8. Digestion. 2006. PMID: 16498253 Review.

2

Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon.

Latella G, Pimpo MT, Sottili S, Zippi M, Viscido A, Chiaramonte M, Frieri G. Latella G, et al. Among authors: frieri g. Int J Colorectal Dis. 2003 Jan;18(1):55-62. doi: 10.1007/s00384-002-0396-5. Epub 2002 May 9. Int J Colorectal Dis. 2003. PMID: 12458383 Clinical Trial.

3

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis.

Frieri G, Giacomelli R, Pimpo M, Palumbo G, Passacantando A, Pantaleoni G, Caprilli R. Frieri G, et al. Gut. 2000 Sep;47(3):410-4. doi: 10.1136/gut.47.3.410. Gut. 2000. PMID: 10940280 Free PMC article.

4

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis.

Frieri G, Pimpo M, Galletti B, Palumbo G, Corrao G, Latella G, Chiaramonte M, Caprilli R. Frieri G, et al. Dig Liver Dis. 2005 Feb;37(2):92-6. doi: 10.1016/j.dld.2004.09.017. Dig Liver Dis. 2005. PMID: 15733520 Clinical Trial.

5

Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment.

Frieri G, Pimpo MT, Palumbo GC, Onori L, Viscido A, Latella G, Galletti B, Pantaleoni GC, Caprilli R. Frieri G, et al. Aliment Pharmacol Ther. 1999 Nov;13(11):1413-7. doi: 10.1046/j.1365-2036.1999.00642.x. Aliment Pharmacol Ther. 1999. PMID: 10571596 Free article. Clinical Trial.

6

Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.

Frieri G, Pimpo MT, Palumbo G, Tonelli F, Annese V, Sturniolo GC, Andreoli A, Comberlato M, Corrao G, Caprilli R. Frieri G, et al. Am J Gastroenterol. 2000 Jun;95(6):1486-90. doi: 10.1111/j.1572-0241.2000.2083_1.x. Am J Gastroenterol. 2000. PMID: 10894584

7

Effects of cisapride on abnormally prolonged endogastric alkalinity time and delayed gastric emptying in cirrhotic patients.

Pimpo MT, Frieri G, Saltarelli P, Ciccocioppo R, Aggio A, Marchetti G, Taddei G, Carlei F, Lygidakis NJ, Onori L. Pimpo MT, et al. Among authors: frieri g. Hepatogastroenterology. 1996 Nov-Dec;43(12):1678-84. Hepatogastroenterology. 1996. PMID: 8975988

8

Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto.

Frieri G, Pimpo MT, Andreoli A, Annese V, Comberlato M, Corrao G, Palumbo G, Sturniolo GC, Tonelli F, Caprilli R. Frieri G, et al. Aliment Pharmacol Ther. 1999 May;13(5):577-82. doi: 10.1046/j.1365-2036.1999.00501.x. Aliment Pharmacol Ther. 1999. PMID: 10233180 Free article.

9

An unusual treatment for a colonic polyp.

Viscido A, Aratari A, Pimpo M, D'Ovidio V, Frieri G, Caprilli R, Crobu M, Porpora MG. Viscido A, et al. Among authors: frieri g. Gut. 2004 Jul;53(7):1000, 1019. doi: 10.1136/gut.2003.026963. Gut. 2004. PMID: 15194651 Free PMC article. No abstract available.

10

Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients.

Giacomelli R, Passacantando A, Frieri G, Parzanese I, D'Alò S, Vernia P, Pimpo MT, Petrucci C, Caprilli R, Cifone MG, Tonietti G. Giacomelli R, et al. Among authors: frieri g. Clin Exp Immunol. 1999 Jan;115(1):72-7. doi: 10.1046/j.1365-2249.1999.00741.x. Clin Exp Immunol. 1999. PMID: 9933422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page